GlassScriptPhysician profile
Barry Schlafstein
NPI 1538213111
$1,573.47
in general payments reported to CMS, 2019-2025
13 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $13.50 · 2021: $128 · 2022: $35.92 · 2023: $54.90 · 2024: $132 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $891.60 | 2019-2021 | |
| Hologic Sales and Service, LLC | $154.77 | 2022-2025 | Acessa Provu System |
| Karl Storz Endoscopy-America | $131.54 | 2024 | Image1 S Connect |
| Intuitive Surgical, INC. | $106.05 | 2025 | |
| Abbvie INC. | $58.19 | 2021-2025 | |
| Ethicon US, LLC | $57.88 | 2019-2023 | Harmonic |
| Amag Pharmaceuticals, INC. | $54.87 | 2019 | |
| Coloplast Corp | $38.06 | 2023-2025 | Restorelle |
| Astellas Pharma US INC | $19.84 | 2025 | Veozah |
| Medtronic, INC. | $17.54 | 2025 | Altaviva |
| Minerva Surgical, INC | $16.83 | 2025 | |
| Avion Pharmaceuticals | $13.18 | 2022 | |
| Axonics, INC. | $13.12 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Schlafstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.